Reference entry · Synthetic tetrapeptide bioregulator
Ovagen
Also known as: Glu-Asp-Leu · EDL tetrapeptide bioregulator
- Class
- Synthetic tetrapeptide bioregulator
- Size
- 4 amino acids
- Primary targets (literature)
- Hepatocyte and liver-aging literature
- Regulatory context
- Not FDA-approved. Hepatic preclinical literature does not establish liver disease treatment claims.
Overview
Ovagen is a Glu-Asp-Leu tetrapeptide bioregulator associated with liver and hepatocyte aging research in the Khavinson literature. Catalog supply should be verified as the defined tetrapeptide, not an undisclosed liver extract.
Mechanism in research literature
Published work describes hepatocyte proliferation, detoxification enzyme expression, and liver aging markers in rodent models following bioregulator exposure.
Common research focus areas
- Hepatocyte culture and liver enzyme assays
- Liver aging and fibrosis rodent models
- Tetrapeptide MS identity confirmation
- Distinction from glutathione and antioxidant peptides
Full literature roundup
Read the cited research summary
A Glu-Asp-Leu tetrapeptide bioregulator associated with liver and hepatocyte aging research. What the Khavinson literature reports — and how it differs from antioxidant peptides.
Ovagen research roundup · 7 minEvaluate catalog material
- COA literacy — read batch documentation before comparing vendors.
- Peptide identity testing — why sequence confirmation matters beyond purity %.
- How we vet sources — our score methodology for recommended vendors.